Colorectal cancer: Tipping the scales

by Ludwig Maximilian University of MunichMicrograph of an organoids, which were generated from intestinal epithelial cells cultered ex vivo. Ap4-deficient organoids formed less protrusions/crypts

Updated on: March 01,2024

Colorectal cancer: Tipping the scales

by Ludwig Maximilian University of MunichMicrograph of an organoids, which were generated from intestinal epithelial cells cultered ex vivo. Ap4-deficient organoids formed less protrusions/crypts

Updated on:March 01,2024

Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal

by ECOG-ACRIN Cancer Research GroupCredit: CC0 Public DomainResults from a clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) show a striking improvement for patients who received che

Updated on: September 28,2024

Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal

by ECOG-ACRIN Cancer Research GroupCredit: CC0 Public DomainResults from a clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) show a striking improvement for patients who received che

Updated on:September 28,2024

Six-fold increase in rural cancer screenings with remote outreach

byOhio State University Medical CenterCredit: Unsplash/CC0 Public DomainRural women are six times more likely to get timely breast, cervical and colorectal cancer screening with remote outreach

Updated on: January 07,2024

Six-fold increase in rural cancer screenings with remote outreach

byOhio State University Medical CenterCredit: Unsplash/CC0 Public DomainRural women are six times more likely to get timely breast, cervical and colorectal cancer screening with remote outreach

Updated on:January 07,2024

Phase 1 study: New medicine extends terminally-ill cancer patients' lives

by Norwegian University of Science and TechnologyMarit Otterlei (center) is a professor at the Norwegian University of Science and Technology. A new cancer drug developed by her and her colleague

Updated on: February 18,2024

Phase 1 study: New medicine extends terminally-ill cancer patients' lives

by Norwegian University of Science and TechnologyMarit Otterlei (center) is a professor at the Norwegian University of Science and Technology. A new cancer drug developed by her and her colleague

Updated on:February 18,2024

Blood cancers: Expert explains what you need to know

by Robin FosterBlood cancer is not a diagnosis anyone wants to receive, but understanding the different types of this disease and how best to catch them early is essential, one expert says.First, bloo

Updated on: November 10,2024

Blood cancers: Expert explains what you need to know

by Robin FosterBlood cancer is not a diagnosis anyone wants to receive, but understanding the different types of this disease and how best to catch them early is essential, one expert says.First, bloo

Updated on:November 10,2024

Study finds new, unexpected mechanism of cancer cell spread

by Keck School of Medicine of USCResearchers from the Keck School of Medicine of USC used imaging techniques to study how the protein GRP78 controls cancer cell behavior. In the top row, human lu

Updated on: January 30,2024

Study finds new, unexpected mechanism of cancer cell spread

by Keck School of Medicine of USCResearchers from the Keck School of Medicine of USC used imaging techniques to study how the protein GRP78 controls cancer cell behavior. In the top row, human lu

Updated on:January 30,2024

Pancreatic lesions may occur more frequently than previously thought

by American Association for Cancer ResearchThe Pancreas. Credit: Illustration from Anatomy & Physiology Connexions Web sitehttp://cnx.org/content/col11496/1.6//Wikimedia Commons,C

Updated on: February 20,2024

Pancreatic lesions may occur more frequently than previously thought

by American Association for Cancer ResearchThe Pancreas. Credit: Illustration from Anatomy & Physiology Connexions Web sitehttp://cnx.org/content/col11496/1.6//Wikimedia Commons,C

Updated on:February 20,2024

New therapy strengthens the immune system's counterattack on skin cancer

by Peter Aagaard Brixen, DTU (Technical University of Denmark)Stained electron micrograph of a T cell. Scientists have shown in laboratory experiments that they are able to create a large number of th

Updated on: July 08,2024

New therapy strengthens the immune system's counterattack on skin cancer

by Peter Aagaard Brixen, DTU (Technical University of Denmark)Stained electron micrograph of a T cell. Scientists have shown in laboratory experiments that they are able to create a large number of th

Updated on:July 08,2024

Researchers identify new way to make cancer self-destruct

by Perelman School of Medicine at the University of PennsylvaniaATF4 is at a point after both pathways come back together. Credit: Penn MedicineFor years, researchers have been trying to target a

Updated on: June 19,2024

Researchers identify new way to make cancer self-destruct

by Perelman School of Medicine at the University of PennsylvaniaATF4 is at a point after both pathways come back together. Credit: Penn MedicineFor years, researchers have been trying to target a

Updated on:June 19,2024

New potential cancer-driving genes identified, opening new paths for precision treatments

byInstitute of Cancer ResearchStudy design and number of samples per tumor type included in the analysis. Credit:Nature Genetics(2024). DOI: 10.1038/s41588-024-01785-9Researchers hav

Updated on: December 01,2024

New potential cancer-driving genes identified, opening new paths for precision treatments

byInstitute of Cancer ResearchStudy design and number of samples per tumor type included in the analysis. Credit:Nature Genetics(2024). DOI: 10.1038/s41588-024-01785-9Researchers hav

Updated on:December 01,2024

The HILPDA protein: A potential biomarker for new treatment options in aggressive kidney cancer

by Karolinska InstitutetCredit:Proceedings of the National Academy of Sciences(2024). DOI: 10.1073/pnas.2310479121Anew studyfrom Karolinska Institutet discovered that bloc

Updated on: March 05,2024

The HILPDA protein: A potential biomarker for new treatment options in aggressive kidney cancer

by Karolinska InstitutetCredit:Proceedings of the National Academy of Sciences(2024). DOI: 10.1073/pnas.2310479121Anew studyfrom Karolinska Institutet discovered that bloc

Updated on:March 05,2024

The tumor environment can affect breast cancer prognosis

byLund UniversityFlowchart of included and excluded patients and representative pictures of each CAV1 staining category in stroma and cytoplasm. Credit:Translational Oncology(2022).

Updated on: January 22,2024

The tumor environment can affect breast cancer prognosis

byLund UniversityFlowchart of included and excluded patients and representative pictures of each CAV1 staining category in stroma and cytoplasm. Credit:Translational Oncology(2022).

Updated on:January 22,2024